Bausch Health Launches 2026 ASPIRE HIGHER Scholarship Program for Dermatology Students Bausch Health introduces the 2026 ASPIRE HIGHER Scholarship Program aimed at supporting students affected by dermatologic conditions, with awards up to $10,000.

Bausch Health Launches 2026 ASPIRE HIGHER Scholarship Program for Dermatology Students #Canada #scholarship #Laval #Bausch_Health #Ortho_Dermatologics

Connecticut Settles with Generic Drug Makers Over Pricing Allegations Impacting Consumers Recent settlements in Connecticut allow consumers who purchased generic drugs to receive payments for overinflated prices. Details outlined.

Connecticut Settles with Generic Drug Makers Over Pricing Allegations Impacting Consumers #United_States #Hartford #Generic_Drugs #Bausch_Health #Lannett_Company

Bausch Health's Solta Medical Unveils Innovative Clear + Brilliant® Touch Laser in Canada Bausch Health's aesthetics division, Solta Medical, is launching the Clear + Brilliant® Touch laser in Canada, expanding effective skin rejuvenation options.

Bausch Health's Solta Medical Unveils Innovative Clear + Brilliant® Touch Laser in Canada #Canada #Laval,_QC #Bausch_Health #Clear_+_Brilliant #Solta_Medical

Bausch Health's OraPharma Celebrates 25 Years of Pioneering ARESTIN® in Dental Care Bausch Health's dental division, OraPharma, marks 25 years of ARESTIN®, the first FDA-approved antibiotic for periodontal treatment, showcasing its legacy in dental care.

Bausch Health's OraPharma Celebrates 25 Years of Pioneering ARESTIN® in Dental Care #Canada #Laval #Bausch_Health #ARESTIN #OraPharma

Bausch Health's Strong Financial Performance in 2025: Key Highlights and Future Outlook Bausch Health Companies Inc. reports impressive Q4 and full-year 2025 results, showing robust revenue growth and strategic acquisitions aimed at enhancing operational excellence and market presence.

Bausch Health's Strong Financial Performance in 2025: Key Highlights and Future Outlook #None #Financial_Performance #2025_results #Bausch_Health

Bausch Health Launches 2026 Gastrointestinal Health Scholars Initiative for Students Bausch Health unveils the 2026 Salix Gastrointestinal Health Scholars Program, offering up to $10,000 scholarships for students affected by GI diseases.

Bausch Health Launches 2026 Gastrointestinal Health Scholars Initiative for Students #Canada #Laval #Bausch_Health #Salix_Pharmaceuticals #GI_Scholars

Bausch Health Shares Insights on RED-C Phase 3 Clinical Trial Results Bausch Health announces the outcomes of the pivotal Phase 3 RED-C trial assessing a new treatment for hepatic encephalopathy in liver cirrhosis patients.

Bausch Health Shares Insights on RED-C Phase 3 Clinical Trial Results #Canada #Laval #Bausch_Health #RED-C #Hepatic_Encephalopathy

Bausch Health's Leadership Set to Attend the J.P. Morgan Healthcare Conference in San Francisco Bausch Health Companies Inc. announces CEO Thomas J. Appio will participate in the upcoming 44th Annual J.P. Morgan Healthcare Conference. Tune in for live updates.

Bausch Health's Leadership Set to Attend the J.P. Morgan Healthcare Conference in San Francisco #United_States #San_Francisco #Healthcare_Conference #Bausch_Health #Thomas_Appio

Bausch Health Enhances Liver Disease Solutions with DURECT Acquisition Bausch Health's recent acquisition of DURECT Corporation aims to bolster its liver disease treatment portfolio, focusing on innovative therapies.

Bausch Health Enhances Liver Disease Solutions with DURECT Acquisition #Canada #Larsucosterol #DURECT_Corporation #Laval #Bausch_Health

DURECT Corporation Announces Q2 2025 Financial Results and Bausch Health Acquisition Update DURECT Corporation reveals its second quarter 2025 financial performance while providing insights into its pending acquisition by Bausch Health, including a cash offer and milestone payments.

DURECT Corporation Announces Q2 2025 Financial Results and Bausch Health Acquisition Update #USA #Acquisition #Cupertino #DURECT_Corporation #Bausch_Health

Must-Read Highlights: 11 Essential Health Press Releases This Week Stay updated with the week’s most significant healthcare press releases covering innovative treatments, partnerships, and more.

Must-Read Highlights: 11 Essential Health Press Releases This Week #United_States #New_York #Aetna #Health_Press #Bausch_Health

Bausch Health's Strategic Acquisition of DURECT Corporation for Liver Disease Innovation Bausch Health strengthens its pipeline by acquiring DURECT Corporation, focusing on innovative treatments for liver diseases, especially alcoholic hepatitis.

Bausch Health's Strategic Acquisition of DURECT Corporation for Liver Disease Innovation #United_States #Liver_Disease #DURECT_Corporation #Laval #Bausch_Health